[1]
Shehzadi, N. et al. 2018. Hypoglycemic, hepatoprotective and molecular docking studies of 5-[(4-chlorophenoxy) methyl]-1, 3, 4-oxadiazole-2-thiol. Bangladesh Journal of Pharmacology. 13, 2 (May 2018), 149–156. DOI:https://doi.org/10.3329/bjp.v13i2.35514.